Cleopatra Hospital is trading at $16.35, down 3.25%, amid broader healthcare-sector weakness.

  • No clear company-specific announcement explains the September 9, 2026 decline.
  • Recent H1 reporting showed revenue growth to EGP 4.309 billion, but profit fell 39.97% year-on-year; available sector data showed Cleopatra Hospital down 2.82% as Egyptian healthcare shares broadly weakened.
  • Egypt’s broader market fell on September 8, with EGX30 down 0.8% amid foreign and Arab investor selling.